Neonatal-Perinatal Medicine
About Our Research
Research efforts within the Division of Neonatal-Perinatal Medicine include projects involving low birth weight, necrotizing enterocolitis, preterm infants, quality improvements within Neonatal Intensive Care Units, pharmacology in infants and neonates, neurodevelopmental disabilities, neonatal epidemiology, long term outcomes of premature infants, prevention of premature labor and birth, patent ductus arteriosus, infant malnutrition and growth stunting, lung disease of prematurity, healthcare initiatives in low and middle income countries and many more.
Our faculty collaborates in these projects with colleagues across campus, including researchers working throughout the School of Medicine, the Carolina Population Center, the Eshelman School of Pharmacy, and the Gillings School of Global Public Health. The division also collaborates extensively with the Pediatric Trials Network and with Duke’s Neonatal Perinatal Research unit as a NICHD Neonatal Research Network site.
Ongoing Clinical Trials and Studies
- Safety of Sildafenil in Premature Infants (SIL02)
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS or POP02)
- Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- Infant Nutrition & Cognition Study
- Studying brain development in infants with developmental disorders
